Search

Taiwo Oladapo

Examiner (ID: 13527, Phone: (571)270-3723 , Office: P/1771 )

Most Active Art Unit
1771
Art Unit(s)
1797, 1771
Total Applications
1276
Issued Applications
617
Pending Applications
137
Abandoned Applications
548

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9662315 [patent_doc_number] => 08809291 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma' [patent_app_type] => utility [patent_app_number] => 13/252148 [patent_app_country] => US [patent_app_date] => 2011-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 22 [patent_no_of_words] => 16369 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13252148 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/252148
Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma Oct 2, 2011 Issued
Array ( [id] => 7742312 [patent_doc_number] => 20120020984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Genetic Markers for Predicting Responsiveness to Combination Therapy' [patent_app_type] => utility [patent_app_number] => 13/249148 [patent_app_country] => US [patent_app_date] => 2011-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 30045 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020984.pdf [firstpage_image] =>[orig_patent_app_number] => 13249148 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/249148
Genetic markers for predicting responsiveness to combination therapy Sep 28, 2011 Issued
Array ( [id] => 8981588 [patent_doc_number] => 08512701 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Anti-CXCL13 and anti-CXCR5 antibodies for the prevention and treatment of cancer and cancer cell migration' [patent_app_type] => utility [patent_app_number] => 13/248904 [patent_app_country] => US [patent_app_date] => 2011-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 22763 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13248904 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/248904
Anti-CXCL13 and anti-CXCR5 antibodies for the prevention and treatment of cancer and cancer cell migration Sep 28, 2011 Issued
Array ( [id] => 7733887 [patent_doc_number] => 20120016111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'Compositions for the treatment of cancer, and methods for testing and using the same' [patent_app_type] => utility [patent_app_number] => 13/241683 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12127 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20120016111.pdf [firstpage_image] =>[orig_patent_app_number] => 13241683 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/241683
Compositions for the treatment of cancer, and methods for testing and using the same Sep 22, 2011 Abandoned
Array ( [id] => 7817469 [patent_doc_number] => 20120064089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'ANTI-CXCL16 AND ANTI-CXCR6 ANTIBODIES FOR THE PREVENTION AND TREATMENT OF CANCER AND CANCER CELL MIGRATION' [patent_app_type] => utility [patent_app_number] => 13/233769 [patent_app_country] => US [patent_app_date] => 2011-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19412 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064089.pdf [firstpage_image] =>[orig_patent_app_number] => 13233769 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/233769
ANTI-CXCL16 AND ANTI-CXCR6 ANTIBODIES FOR THE PREVENTION AND TREATMENT OF CANCER AND CANCER CELL MIGRATION Sep 14, 2011 Abandoned
Array ( [id] => 8221220 [patent_doc_number] => 20120135424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'MER DIAGNOSTIC AND THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 13/230005 [patent_app_country] => US [patent_app_date] => 2011-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 30179 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13230005 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/230005
MER DIAGNOSTIC AND THERAPEUTIC AGENTS Sep 11, 2011 Abandoned
Array ( [id] => 9983802 [patent_doc_number] => 09029516 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Antibodies and molecules derived therefrom that bind to STEAP-1 proteins' [patent_app_type] => utility [patent_app_number] => 13/199539 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 87 [patent_figures_cnt] => 88 [patent_no_of_words] => 90276 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13199539 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/199539
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins Aug 30, 2011 Issued
Array ( [id] => 10919686 [patent_doc_number] => 20140322705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'Cancer diagnostic and cancer therapeutic' [patent_app_type] => utility [patent_app_number] => 13/817687 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 39589 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817687 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/817687
Cancer diagnostic and cancer therapeutic Aug 18, 2011 Abandoned
Array ( [id] => 9107031 [patent_doc_number] => 20130280163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'Antibodies and molecules derived therefrom that bind to STEAP-1 proteins' [patent_app_type] => utility [patent_app_number] => 13/136897 [patent_app_country] => US [patent_app_date] => 2011-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 87 [patent_figures_cnt] => 87 [patent_no_of_words] => 89888 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13136897 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/136897
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins Aug 11, 2011 Issued
Array ( [id] => 7580251 [patent_doc_number] => 20110294134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'METHODS AND KITS FOR DETERMINING A RISK TO DEVELOP CANCER, FOR EVALUATING AN EFFECTIVENESS AND DOSAGE OF CANCER THERAPY AND FOR CORRELATING BETWEEN AN ACTIVITY OF A DNA REPAIR ENZYME AND A CANCER' [patent_app_type] => utility [patent_app_number] => 13/204737 [patent_app_country] => US [patent_app_date] => 2011-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17304 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294134.pdf [firstpage_image] =>[orig_patent_app_number] => 13204737 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/204737
METHODS AND KITS FOR DETERMINING A RISK TO DEVELOP CANCER, FOR EVALUATING AN EFFECTIVENESS AND DOSAGE OF CANCER THERAPY AND FOR CORRELATING BETWEEN AN ACTIVITY OF A DNA REPAIR ENZYME AND A CANCER Aug 7, 2011 Abandoned
Array ( [id] => 7651825 [patent_doc_number] => 20110301094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'NEW TUMOR SUPPRESSOR GENE, P28ING5' [patent_app_type] => utility [patent_app_number] => 13/197595 [patent_app_country] => US [patent_app_date] => 2011-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 30138 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301094.pdf [firstpage_image] =>[orig_patent_app_number] => 13197595 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/197595
NEW TUMOR SUPPRESSOR GENE, P28ING5 Aug 2, 2011 Abandoned
Array ( [id] => 9073914 [patent_doc_number] => 08551490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Genetic products differentially expressed in tumors and use thereof' [patent_app_type] => utility [patent_app_number] => 13/184719 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20654 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13184719 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/184719
Genetic products differentially expressed in tumors and use thereof Jul 17, 2011 Issued
Array ( [id] => 7766031 [patent_doc_number] => 20120034158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis corresponding compositions and kits' [patent_app_type] => utility [patent_app_number] => 13/067998 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7798 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034158.pdf [firstpage_image] =>[orig_patent_app_number] => 13067998 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/067998
Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis corresponding compositions and kits Jul 13, 2011 Abandoned
Array ( [id] => 7670600 [patent_doc_number] => 20110319869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'HUMAN CYTOTOXIC T-LYMPHOCYTE EPITOPE AND ITS AGONIST EPITOPE FROM THE NON-VARIABLE NUMBER OF TANDEM REPEAT SEQUENCE OF MUC-1' [patent_app_type] => utility [patent_app_number] => 13/176341 [patent_app_country] => US [patent_app_date] => 2011-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 38391 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13176341 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/176341
Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1 Jul 4, 2011 Issued
Array ( [id] => 7669102 [patent_doc_number] => 20110318371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Novel serpentine transmembrane antigens expressed in human cancers and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/134650 [patent_app_country] => US [patent_app_date] => 2011-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 21340 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13134650 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/134650
Serpentine transmembrane antigens expressed in human cancers and uses thereof Jun 12, 2011 Issued
Array ( [id] => 7487439 [patent_doc_number] => 20110236383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'Protein Formulation' [patent_app_type] => utility [patent_app_number] => 13/156113 [patent_app_country] => US [patent_app_date] => 2011-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17477 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236383.pdf [firstpage_image] =>[orig_patent_app_number] => 13156113 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/156113
Protein Formulation Jun 7, 2011 Abandoned
Array ( [id] => 8865596 [patent_doc_number] => 20130149298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin' [patent_app_type] => utility [patent_app_number] => 13/154076 [patent_app_country] => US [patent_app_date] => 2011-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 185 [patent_figures_cnt] => 185 [patent_no_of_words] => 110525 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13154076 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/154076
Compositions and methods for the treatment of tumor of hematopoietic origin Jun 5, 2011 Issued
Array ( [id] => 8963115 [patent_doc_number] => 20130202717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'MATERIALS AND METHODS FOR DIAGNOSING AND PREDICTING THE COURSE OF PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 13/700777 [patent_app_country] => US [patent_app_date] => 2011-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8960 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700777 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/700777
MATERIALS AND METHODS FOR DIAGNOSING AND PREDICTING THE COURSE OF PROSTATE CANCER May 31, 2011 Abandoned
Array ( [id] => 7731517 [patent_doc_number] => 20120014942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF MALIGNANT DISEASES' [patent_app_type] => utility [patent_app_number] => 13/116319 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18706 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20120014942.pdf [firstpage_image] =>[orig_patent_app_number] => 13116319 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/116319
Method for the diagnosis and prognosis of malignant diseases May 25, 2011 Issued
Array ( [id] => 6091067 [patent_doc_number] => 20110218329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES' [patent_app_type] => utility [patent_app_number] => 13/105152 [patent_app_country] => US [patent_app_date] => 2011-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 32346 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218329.pdf [firstpage_image] =>[orig_patent_app_number] => 13105152 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/105152
ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES May 10, 2011 Abandoned
Menu